Biopharma News
Biopharma news
-
News The latest patient-centric packaging & drug delivery solutions revealed in Pharmapack 2020 Innovation Gallery
Pharmapack Europe, the leading conference & exhibition in pharma packaging & drug delivery business traded the successful 2020 edition at the beginning of February. The innovation gallery, as the key feature of this event, has gathered the most recent ... -
News More than just wrapping a pill: improving patients’ lives through packaging
There is a great focus on medical packaging as a means of protecting the drug, but there is still a long way to go when talking about the real needs of patients, and what packaging can do for them. For the past six years, Giana Carli Lorenzini,Postdoct... -
News Mylan to acquire Aspen's thrombosis business in Europe
The transaction will further complement and expand Mylan's complex injectables offering and presence in hospitals. -
News Exelixis and Catalent collaborate to develop antibody-drug conjugates
The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology. -
News Mylan and Biocon Biologics launch Lantus biosimilar in the US
Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market. -
News Pfizer sells biologics manufacturing facility in Adelaide
Bridgewest to develop the site into a full-service contract development and manufacturing organization. -
News Oral Solid Dose Regulatory Hurdles and How to Approach Them
In your quest to meet the regulatory requirements for your oral solids project, you may encounter significant hurdles. Anticipating these early on and thoroughly planning your approach can help. Experts in the Pfizer CentreOne global network, Gillian M... -
News New syringe technology could make the 'uninjectable' injectable
Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations. -
News BMS adds lead TGF-beta asset to portfolio through acquisition
Forbius's lead investigational asset, AVID200 holds promise as an effective and well-tolerated therapeutic in fibrotic diseases and immuno-oncology. -
News Catalent expands manufacturing support for COVID-19 vaccine AZD1222
The company will prepare the Harmans facility to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing later this year. -
News CRO Europital opens new UK site in response to urgent demand
The company will target working with small and medium biotechs who require a science-driven, rather than a volume-driven partner. -
News Pharma 2030 and Packaging
An exclusive interview with Mr. Sudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance -
News Smart packaging solutions to COVID-19 counterfeiting
Developments in smart packaging can add value to the pharmaceutical supply chain and help to tackle the threat of counterfeit products as the race towards producing a COVID-19 vaccine heats up Dr Alex Cole, Senior Strategic Marketing Manager, CPI -
News Cobra Biologics completes production of master cell banks for epilepsy gene therapy drug candidate
This milestone secures future production of CombiGene's CG01 drug candidate to treat drug-resistant focal epilepsy. -
News J&J agrees in principle to supply UK with its COVID-19 vaccine candidate
Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators. -
News Sanofi galvanizes strategic product pipeline with Principia Biopharma acquisition
The transaction will enable Sanofi to expand and accelerate development of BTK inhibitors across multiple indications, including MS and other central nervous system diseases. -
News Moderna inks US deal for 100 million doses of its COVID vaccine
The company is also scaling up its manufacturing capability with its partners — Lonza, Catalent and Rovi — should the vaccine get the green light. -
News Lonza expands microbial capacity and extends partnership with Servier for L-asparaginase API manufacturing
New mid-scale microbial facility will support Servier with API for acute lymphoblastic leukemia therapies. -
News Oxford Biomedica signs 3-year CSA for Parkinson’s disease gene therapy program
The company expects to manufacture the clinical-stage gene therapy product in its commercial-scale GMP manufacturing facilities. -
News Sanofi and GSK in advanced discussions with EU to supply up to 300 million doses of COVID-19 vaccine
Discussions relate to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system. -
News Pfizer and BioNTech to supply Japan with 120 million doses of mRNA-based vaccine candidate
The companies are set to manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021. -
News Catalent to create European clinical manufacturing center of excellence in France
The $30 million investment will enable the site to handle large-molecule programs, with additional capacity for small molecule dosage form development. -
News Stevanato Group and Colanar colaborate to study container closure systems
The data generated through the partnership will help biopharma companies to develop robust manufacturing processes and minimize challenges during scale-up and commercialization. -
News Humanigen expands partnership with Catalent to manufacture investigational COVID-19 therapeutic candidate
Data on the first clinical use of lenzilumab in patients with severe COVID-19 pneumonia suggest promising results. -
News ChargePoint Technology and STERIS collaborate to offer fully validated sterile transfer solution
Sterile transfer solutions without compromising operational efficiency. -
News China's first SARS-CoV-2 neutralizing antibody enters clinical trials
Junshi Biosciences cites Lonza’s GS Xceed gene expression system as a critical enabler for the program. -
News Cobra Biologics delivers final plasmids for CombiGene's epilepsy project
Further milestone paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy. -
News Rentschler Biopharma and Vetter team up to simplify processes
Companies agree that the key to tackling drug development complexity is collaboration. -
News iNova Pharmaceuticals announces the launch of iPitch 2020
Following on from the success of the inaugural iPitch launch in 2019, iNova Pharmaceuticals is delighted to announce the launch of a new round of iPitch challenges for 2020. -
News Ajinomoto introduces fast track platform for drug product manufacturing
AJILITY is designed to speed novel or existing therapeutics from development to manufacturing and into the clinic. -
News PCI Pharma Services completes biotech Center of Excellence
The global outsourcing solutions provider is also set to expand its biotech capabilities in Europe. -
News FDA approves new Dupixent prefilled pen
The prefilled pen supports more convenient self-administration for patients with chronic type 2 inflammatory diseases. -
News Press Release > CordenPharma & Moderna Extend Lipid Supply Agreement for Moderna’s (mRNA-1273) Vaccine Candidate
Luxembourg, 28 May 2020 -- CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agr... -
News Emergent to invest $75 million in viral vector manufacturing expansion at Massachusetts site
The investment will add a multi-suite operation to the Canton facility, adding up to 1000L of viral vector capacity and is expected to go online by 2023 -
News BIA Separations introduces PrimaS multi-mode ligand bioprocessing technology
Novel platform initially focussed on high-resolution industrial-scale processing of therapeutic mRNA. -
News Sanofi to build EUR 490 million vaccine production facility in France
The French pharma company will also invest EUR 120 million to create a new research center at Marcy-l'Etoile dedicated to vaccines -
News Catalent to provide AstraZeneca with finishing and packaging for University of Oxford COVID-19 vaccine candidate
Late-stage manufacturing services will be conducted at Catalent’s facility in Anagni, Italy in preparation for large-scale commercial supply of the vaccine -
News WuXi Biologics signs lease for a clinical manufacturing facility in the US
The deal represents the contract manufacturer's third US site. -
News Fujifilm invests $928 million to expand CDMO's biologics production facility in Denmark
Investment will double the site's drug substance manufacturing capacity and will expand its capabilities to include fill/finish, and enhance its current assembly, labeling and packaging services. -
News Oxford Biomedica and VMIC seal UK vaccine manufacturing capacity deal
The collaboration will significantly increase the UK’s capacity to manufacture viral vectors vaccines as part of a national effort in response to COVID-19. -
News Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centre
The collaboration with CGT Catapult will enable Achilles to increase its GMP manufacturing capacity to supply clinical trials of its novel T cell therapy products. -
News Emergent BioSolutions signs 5-year manufacturing agreement for J&J’s lead COVID-19 vaccine candidate
The CDMO produce drug substance at large scale for commercial manufacturing with the first 2 years valued at approximately $480 million. -
News AGC Biologics acquires AstraZeneca commercial biomanufacturing facility
The Boulder, Colorado, USA facility will increase global capacity and extend manufacturing scale. -
News Emergent bags $628 million "landmark" CDMO deal to produce COVID-19 vaccine candidates
The company will provide CDMO capabilities, capacities, and expertise to support the US government’s Warp Speed Program to pave the way for innovators to advance COVID-19 programs. -
News Stevanato Group to open US Technology Excellence Center in Boston
US TEC will support biopharma drug development throughout the lifecycle, helping them overcome the challenges of the container-closure system. -
News CSL signs up Thermo Fisher in biologics development and manufacturing deal
CDMO will operate new Swiss facility due for completion in 2021 to support production of next-gen haemophilia product -
News AbCellera and Lilly seal multi-year antibody discovery collaboration
AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets. -
News Sifting for gold in the biopharmaceutical talent pool
Evolving biopharma quality demands, the shifting regulatory landscape and the COVID-19 pandemic mean CDMOs will need to get even better at finding talent if they are to strike recruitment gold -
News WuXi Biologics signs land deal to build first US manufacturing facility in Massachusetts biotech hub
$60 million Worcester plant should be operational by 2022 and will employ 150 people -
News US government signs $354 million generics and API manufacturing contract with Phlow
Pharma start-up will use continuous manufacturing to shore up supply chain of essential medicines -
News How far has the pharmaceutical packaging industry come on its journey to sustainability?
At this year’s Pharmapack Europe, we interviewed Gregor Anderson, Managing Director at Pharmacentric Solutions on how the industry is striving for greater sustainability with regards to packaging and devices. -
News CPHI Webinar Series - Pharma Action Against COVID-19 – Listen Now
Listen to recordings of all webinars broadcast during the week of May 04-08 -
News Is COVID-19 the catalyst for Western pharma markets to revert to domestic API production?
The ongoing pandemic has fuelled debate about whether Western pharmaceutical supply chains and API sourcing are too dependent on lower-cost Asian suppliers such as China. Do the US and Europe need to bring manufacturing back home? -
News Evonik launches European API manufacturing capacity expansion programme
EUR 25 million first stage expected to be completed by mid-2021 as COVID-19 pandemic highlights need for more European capacity -
News Gilead outlines plans for global expansion of remdesivir production
Biotech in discussions with pharmaceutical and chemical manufacturers on how to broaden supply of antiviral that last week received an emergency use authorization for treatment of COVID-19 from the FDA -
News Bio-Rad launches anti-certolizumab pegol antibodies
Using this critical antibody reagent at the preclinical stage of development will minimize the need to revalidate assays with different reagents at the clinical development stage. -
News Univercells launches new subsidiary called Univercells Technologies
The new business unit will focus on existing automated biomanufacturing products, as well as launching new technologies. -
News Sartorius closes acquisition of selected assets of Danaher Life Sciences
The addition of various laboratory and bioprocessing technologies will support customers to develop biotech medicines and vaccines. -
News Moderna signs up Lonza to boost scale-up of mRNA vaccine for coronavirus
Collaboration leverages CDMO’s expertise in tech transfer and manufacturing to aim for 1 million doses per day -
News Scaling up and speeding up: pharma’s manufacturing challenges during COVID-19
As biopharma searches for vaccines and treatments to alleviate the crisis, how can companies manage shortened timelines to rapidly develop and manufacture safe and effective products on a global scale? A recent Endpoints webinar sheds some light -
News Strides starts exports of generic version of Avigan for COVID-19 treatment
Antiviral drug has been developed in-house with API manufacturer signed up to secure KSM -
News Merck KGaA to double viral vector capacity through EUR 100 million Carlsbad expansion
Second 140,000 square-foot facility is expected to open next year -
News How drug delivery and device manufacturers can capitalise on the biologics boom
The biologics market is Pharma’s fastest growing market. With such significant growth of a different breed of products, what are the opportunities and implications for pharma packaging and drug delivery manufacturers? -
News Nitrosamine contamination: pharma’s re-evaluation of its supply chain
The detection of nitrosamine impurities in some finished dosages has opened up a whole new set of challenges for API manufacturers who need to perform risk evaluations of their processes -
News Fujifilm ramps up Avigan production as Japanese government stockpiles potential COVID-19 therapy
Japanese drugmaker plans to meet 100,000 treatment course target by July -
News Lupin receives FDA all-clear for Mandideep API manufacturing facility
Company becomes the fourth Indian pharma firm to secure FDA clearance in the last two weeks -
News Alfa Laval launches the first premium separator system for single-use biopharma processing
The CultureOne separator system uses product-contact parts that are replaceable and made from recyclable material. -
News German pharma companies are meeting the corona "stress test"
The head of the leading German pharmaceutical industry organization says German firms are working top-speed to find coronavirus medications. -
News Novel transfection reagent set to alleviate viral vector bottleneck
The FectoVIR-AAV transfection reagent achieves large-scale transient transfection resulting in up to a 10-fold increase in AAV functional viral titer yields in suspension cell systems. -
News Servier strengthens its R&D pipeline with Symphogen acquisition
Symphogen becomes the antibody center of excellence within Servier. -
News FDA orders ranitidine withdrawal due to nitrosamine contamination risk
US drug regulator, the Food and Drug Administration, has ordered the immediate withdrawal of all prescription and over-the-counter versions of heartburn drug, ranitidine – commonly known as Zantac – after concluding certain products may pre... -
News China focused on meeting international API demand amid pandemic, say officials
Our content has now moved to our new Global Pharma Insights website, providing the very latest news and information covering all aspects of the pharmaceutical supply chain. Please click the link below to access this article. -
News The Future of Medicine: What are the therapies of tomorrow?
As biopharma heads towards a new decade, extracting value from innovation remains a key theme in medicines development. However, rather than accepting the traditional model of novel treatments via the R&D pipeline as the innovative focus, the industry ... -
News China focused on meeting international API demand amid pandemic, say officials
China is stepping up its efforts to produce and ship active pharmaceutical ingredients (APIs), with a focus on meeting international demand, particularly for those showing potential to treat the COVID-19 disease, according to Chinese officials on Tuesd... -
News CDMO Ritedose chooses ChargePoint to ensure drug substance mixing process sterility
The Ritedose Corporation, a contract development and manufacturing organisation (CDMO) with a focus on inhalation and ophthalmic products, has partnered with ChargePoint Technology to ensure the sterility of its drug substance mixing process. -
News European patent granted for amatoxin conjugates for tumor therapy
The patent covers the crosslinking of certain carrier molecules, for example, antibodies, via specific binding sites to amatoxins. -
News Alvotech and DKSH partner to bring key biosimilar to Asia
Together, the companies will provide APAC markets with a cost-effective alternative to the largest-selling blockbuster medicine worldwide. -
News ProBioGen selected for development and large-scale manufacturing services
The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development. -
News Lonza's new medium boosts and optimizes AAV production in insect cells
The TheraPEAK SfAAV Medium is specifically designed to support the development of safe, scalable, gene therapies. -
News Biologics: The Driving Force for CDMOs
CDMOs build capacity to capitalise on biologics boom -
News FDB to triple UK microbial production capacity as Fujifilm commits to $83 million investment
Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO. -
News Oxford Biomedica signs LSA with Juno Therapeutics
Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday. -
News What Impact will Coronavirus have on Pharma Supply Chains?
The worldwide inter-dependency of pharmaceutical manufacturing is highlighted by the ongoing Coronavirus situation. How can the global supply of diagnostic kits, drugs, medical supplies, and equipment be sustained to treat patients in the face of suppl... -
News Vaxxas HD-MAP to deliver vaccines directly to the skin
Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch. -
News Artificial Intelligence: Moving beyond efficiency gains in drug development
Is the pharma industry making the most of AI’s potential when it comes to accelerating and enhancing pharmaceutical drug development? -
News Unlocking the potential of cannabinoid-derived drugs
Following the 2018 FDA approval of GW Pharmaceuticals’ Epidiolex®, there has been increased interest in the development of cannabinoid-derived drug substances for innovative new therapies. We examine the state of the market and future potenti... -
News Sartorius simplifies biologics production with new bioreactor
Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform. -
News Potential first-in-class treatment reaches significant milestone
The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis. -
News Trump and pharma execs to discuss progress on COVID-19 cure
The White House task force and the US President will meet drug makers this afternoon to discuss "progress on a vaccine and cure". -
News Packaging Toward a Sustainable Future
With the world’s attitude to tackling climate change arguably the global number one hot topic of 2019, the issue of sustainability is an emerging theme in pharmaceutical packaging. -
News BIA Separations signs agreement to commercialise novel elution technology
Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy. -
News New Sartorius QbD tool supports faster Raman model building
Unlocking the potential of Raman spectroscopy as a high throughput analytical technique for monitoring cell culture in mini bioreactors. -
News Pipelines, Economics and IP: How Bioprocessing Tech Firms Assess Markets
Identifying areas of unmet need to guide R&D strategy and shape drug pipelines -
News Univercells' €50M investment to speed delivery of manufacturing tech
The investment will support continued expansion into the fast-growing gene therapy segment, including new developments that will enable a range of best-in-class solutions for viral manufacturing. -
News Sphere Fluidics expands to increase supply of surfactant for droplet microfluidics
Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant. -
News Sartorius sharpens its brand focus
The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster. -
News US Pharma Outlook: Ten Trends to Look Out For in 2020
With CPHI North America fast approaching, we asked several industry experts what they see as the main trends emerging across the US pharma supply chain this year. -
News Inovio and Beijing Advaccine to advance vaccine against Coronavirus
Agreement will facilitate clinical trial translations in China. -
News First human trial of monoclonal antibody to prevent malaria opens
If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common. -
News Merck invests in biotech development facility in Switzerland
€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing. -
News Grey Wolf Therapeutics secures funding for cancer therapies development
The company targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system. -
News Wuxi to acquire Bayer final drug product manufacturing site
First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities. -
News BioMarin gets go-ahead to start gene therapy clinical trials
BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program. -
News Intensification and Consistency: Driving Biomanufacturing Innovation
Biopharma’s desire for fast, cheap production and cell and gene therapy firms’ need for consistency is shaping tech development in the sector. -
News Partnership formed to develop and commercialise ready-to-use medicine
The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products. -
News UCB to build new biotech manufacturing plant in Belgium
Capacity to serve global late-stage development and commercial manufacturing of monoclonal antibody drug substance to support new product launches. -
News Sartorius tests and develops AI in its products and platforms
Customers and partners look set to benefit from reduced development times and costs of medical drugs. -
News Pharma Outlook: 10 Trends to Look Out For in 2020
We asked ten industry experts for their thoughts on some of the emerging trends for the pharmaceutical supply chain as the industry enters 2020... -
News 'Niche' CMO invests in UK facility to expand viral vector sterile manufacturing
CMO's customer base has grown by more than 25% in 2019 alone, and investment and demand for services is estimated to increase output by another 25-30% in 2020. -
News Sanofi bolsters its immuno-oncology pipeline for $2.5B
Lead asset THOR-707 being explored across multiple solid tumor types alone and in combination with immune checkpoint inhibitors and other future IO combinations. -
News Eli Lilly unveils shared innovation laboratory in San Francisco
Lilly Gateway Labs will provide biotech companies direct access to Lilly scientists and expertise. -
News New single-use mixing system offers rapid and homogenous mixing
ClearMixx performs liquid/liquid and powder/liquid mixing, with a dispersion plate able to efficiently mix the most challenging buffer, media and biopharmaceutical ingredients. -
News India pharma forecast to grow strongly in 2020
The rise in exports growth potential is believed to be in response to concerted reforms by the CDSCO and industry quality improvements in the last few years. -
News GVK Bio continues to see growth tailwinds for 2020 thanks to a ‘crescendo of factors’
China-US trade challenges has led to de-risking by pharma companies. -
News Winners of the 16th Pharma Awards
Companies and individuals from across the whole pharma supply chain recognised for their excellence and commitment. -
News CDMOs to benefit from rising BTDs, orphan drugs and fast track status therapies
But personalized medicines will require new logistics and manufacturing systems. -
News Europe predicted to surpass the US in biologic manufacturing capacity by 2023
Demand for biological manufacturing is growing faster than capacity growth. -
News Legacy recruits heavily to meet growing steriles demand
Company to reach 250 employees by year end to meet growing drug product manufacturing demand. -
News China on course for 'massive' bio capacity shortfall
A shortage of qualified personnel may be a drag factor in cell and gene therapies; in China 100,00L of capacity will need to be added every year to meet bio demand.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance